Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen

Sex: All

Age: 18 - 70+

Code: NCT06800053

Recruiting

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

for
Malignant Digestive System Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07456852

Phase 1, Phase 2, Recruiting

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

for
Refractory Solid Tumor, Hepatocellular Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT05468359

Phase 1, Phase 2, Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: North Haven CT, New Haven CT, Deerfield Beach FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase 1, Recruiting

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Brunswick NJ, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07128303

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

SLV-324 Treatment of Metastatic Solid Tumors

for
Metastatic Solid Tumors
Location: Philadelphia PA, Cleveland OH, St Louis MO, Houston TX,
Sponsor: Solve Therapeutics

Sex: All

Age: 18+

Code: NCT07108114

Phase 1, Recruiting

Prevent Cancer- Greenville

for
Cancer, High-Risk Cancer
Location: Greenville SC
Sponsor: Prisma Health-Upstate

Sex: All

Age: 18+

Code: NCT04947098

Recruiting

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Haven CT, Baltimore MD, Birmingham AL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07226349

Phase 1, Recruiting

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Lake Success NY, Grand Rapids MI
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07387068

Phase 1, Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase 1, Recruiting

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

for
Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer,
Location: Boston MA, New Haven CT, Sarasota FL, Houston TX,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT07578571

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, New Orleans LA, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07220447

Early Phase 1, Recruiting

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

for
Advanced Malignant Solid Neoplasm, Malignant Brain Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 39

Code: NCT07174661

Recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03819296

Phase 1, Recruiting

Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer

for
Metastatic Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT07197671

Phase 1, Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

for
HER2-Positive Solid Tumor
Location: Nashville TN
Sponsor: Yuhan Corporation

Sex: All

Age: 18+

Code: NCT05523947

Phase 1, Phase 2, Recruiting

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Charleston SC, Augusta GA, Greenville SC, Anderson SC,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06279013

Recruiting

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05904782

Recruiting

A Study of JNJ-1761981 in Participants With Solid Tumors

for
Neoplasms
Location: The Bronx NY, Jacksonville FL, Rochester MN, Houston TX
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT07525141

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial